Darifenacin Hydrobromide is Used for treating a disease of altered motility or tone of smooth muscle and urinary incontinence. It was first introduced by Abbvie Inc in its drug Enablex on Dec 22, 2004. 10 different companies have introduced drugs containing Darifenacin Hydrobromide.
Darifenacin Hydrobromide Patents
Given below is the list of patents protecting Darifenacin Hydrobromide, along
with the drug name that holds that patent and the company name owning that
drug.
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Darifenacin Hydrobromide Generic API Manufacturers
Several generic applications have been filed for Darifenacin Hydrobromide. The first generic version for Darifenacin Hydrobromide was by Endo Operations Ltd and was approved on Mar 13, 2015. And the latest generic version is by Polygen Pharmaceuticals Inc and was approved on Jan 6, 2020.
Given below is the list of companies who have filed for
Darifenacin Hydrobromide generic, along with the locations of their manufacturing plants worldwide.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. Given below are the
details of the strengths of this generic introduced by
Alembic.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 7.5MG BASE
tablet, extended release
Prescription
ORAL
AB
Dec 8, 2017
EQ 15MG BASE
tablet, extended release
Prescription
ORAL
AB
Dec 8, 2017
Manufacturing Plant Locations
New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. Given below are the
details of the strengths of this generic introduced by
Aurobindo Pharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 7.5MG BASE
tablet, extended release
Prescription
ORAL
AB
Sep 19, 2016
EQ 15MG BASE
tablet, extended release
Prescription
ORAL
AB
Sep 19, 2016
Manufacturing Plant Locations
New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
Country
City
Firm Name
India
Medchal
Aurobindo Pharma Ltd
Sangareddy
Aurobindo Pharma Limited
Polepally, Mahaboob Nagar
Aurobindo Pharma Limited
Bachupally
Aurobindo Pharma Limited
United States
East Windsor
Aurobindo Pharma USA Inc
3. CIPLA
Cipla Ltd has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. Given below are the
details of the strengths of this generic introduced by
Cipla.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 7.5MG BASE
tablet, extended release
Prescription
ORAL
AB
Sep 1, 2016
EQ 15MG BASE
tablet, extended release
Prescription
ORAL
AB
Sep 1, 2016
Manufacturing Plant Locations
New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
Country
City
Firm Name
India
Bengaluru
Cipla Limited
Bangalore
Cipla Ltd.
Vasco Da Gama
Cipla Limited
Pithampur, District Dhar
Cipla Limited
Mumbai
Cipla Limited
Raigad
Cipla Limited
Kurkumbh Village, Dist. Pune
Cipla, Ltd.
4. ENDO OPERATIONS
Endo Operations Ltd has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. Given below are the
details of the strengths of this generic introduced by
Endo Operations.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 7.5MG BASE
tablet, extended release
Discontinued
ORAL
N/A
Mar 13, 2015
EQ 15MG BASE
tablet, extended release
Discontinued
ORAL
N/A
Mar 13, 2015
5. JUBILANT GENERICS
Jubilant Generics Ltd has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. Given below are the
details of the strengths of this generic introduced by
Jubilant Generics.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 7.5MG BASE
tablet, extended release
Discontinued
ORAL
N/A
Oct 12, 2016
EQ 15MG BASE
tablet, extended release
Discontinued
ORAL
N/A
Oct 12, 2016
Manufacturing Plant Locations
New
Jubilant Generics's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Jubilant Generics as present at those locations.
Country
City
Firm Name
India
Roorkee
Jubilant Generics Limited
6. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. All of these versions come by the name DARIFENACIN. Given below are the
details of the strengths of this generic introduced by
Macleods Pharms Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 7.5MG BASE
tablet, extended release
Prescription
ORAL
AB
Jul 28, 2017
EQ 15MG BASE
(reference standard)
tablet, extended release
Prescription
ORAL
AB
Jul 28, 2017
7. POLYGEN PHARMS
Polygen Pharmaceuticals Inc has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. Given below are the
details of the strengths of this generic introduced by
Polygen Pharms.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 7.5MG BASE
tablet, extended release
Prescription
ORAL
AB
Jan 6, 2020
EQ 15MG BASE
tablet, extended release
Prescription
ORAL
AB
Jan 6, 2020
8. TORRENT
Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. Given below are the
details of the strengths of this generic introduced by
Torrent.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 15MG BASE
tablet, extended release
Prescription
ORAL
AB
Nov 17, 2016
EQ 7.5MG BASE
tablet, extended release
Prescription
ORAL
AB
Nov 17, 2016
Manufacturing Plant Locations
New
Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.
Country
City
Firm Name
India
Bharuch
Torrent Pharmaceuticals Limited
Pithampur
Torrent Pharmaceuticals Limited
Indrad
Torrent Pharmaceuticals Limited
Gandhi Nagar
Torrent Pharmaceuticals Limited
Thanam
Torrent Pharmaceuticals Limited
United States
Kalamazoo
Torrent Pharma Inc.
Basking Ridge
Torrent Pharma Inc.
9. XIROMED
Xiromed Pharma Espana Sl has filed for 2 different strengths of generic version for Darifenacin Hydrobromide. Given below are the
details of the strengths of this generic introduced by
Xiromed.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 15MG BASE
tablet, extended release
Discontinued
ORAL
N/A
Oct 22, 2019
EQ 7.5MG BASE
tablet, extended release
Discontinued
ORAL
N/A
Oct 22, 2019
Manufacturing Plant Locations
New
Xiromed's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Xiromed as present at those locations.
